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Bovine and human aB-crystallin undergo deamidation upon aging in the lens. In bovine aB-crystallin, the specific site of deamidation has been 
identified by peptide mapping after tryptic digestion. Asn-146 was found to be subject o deamidation, whereas the only other asparagine residue, 
at position 78, is not affected. Asn-146 is flanked at the carboxylic side by a glycyl residue. Yet, the rate of in viva deamidation is low. In vitro 
studies reveal that the deamidation is accompanied by signilicant racemization, indicating that the deamidation proceeds via formation of a 
succinimide intermediate. 
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1. INTRODUCTION 
One of the most abundant structural proteins in the 
eye lens is a-crystallin. This protein occurs as large 
water-soluble aggregates (up to lo6 Da) and is com- 
posed of two types of related subunits, aA- and aB- 
crystallin. The absence of protein turnover in the inner 
part of the lens makes it necessary that the crystallins 
are extremely stable and long-living proteins [l]. a- 
Crystallin is therefore an excellent model for the study 
of in vivo aging of proteins. a-Crystallins also occur in 
several cell types and organs outside the lens [2,3] and 
increased levels of aB-crystallin have been observed in 
several neurological disorders [4,5] and in cell lines 
under stress conditions [6]. There is a striking sequence 
homology between a-crystallin and the small heat- 
shock proteins [7,8]. Recent studies demonstrate that 
they also have functional similarities [6] and that both 
a-crystallin and the small heat shock proteins can func- 
tion as molecular chaperones [9-l 11. 
From this functional point of view it is relevant to 
increase the understanding of the stability and in vivo 
modification of a-crystallin. It has been shown that 
both aA- and aB-crystallin undergo various posttrans- 
lational modifications, both enzymatic and nonenzy- 
matic [ 1,12,13]. Deamidation is one of the major nonen- 
zymatic modifications in aging proteins [14] and consti- 
tutes indeed a problem of considerable concern in pro- 
tein engineering [15]. Deamidation was proposed at an 
early stage to contribute to the observed charge hetero- 
geneity of the a-crystallin chains [16]. Only more re- 
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cently could the specific sites of deamidation in chicken 
and bovine aA-crystallin [17,18] be established. In the 
present study we describe the age-dependent site-spe- 
cific deamidation of bovine aB-crystallin at Asn-146. 
2. EXPERIMENTAL 
Bovine eye lenses of different ages were obtained through the Cen- 
tral Animal Facilities of the University of Nijmegen, School of Med- 
icine. Human lenses were provided by Dr. G. Vrensen (the Nether- 
lands Ophthalmic Research Institute, Amsterdam) and by Dr. M. 
Hogeweg (Academic Hospital, Leiden). 
a-Crystallin from calf lens cortex (6-month-old), bovine lens nu- 
cleus (5-year-old) and human lenses (75- to 85-year-old) was isolated 
from the water-soluble fraction by gel permeation chromatography on 
Ultrogel AcA-34 (Pharmacia LKB). Bovine aB-crystallin was purified 
by ion-exchange chromatography on DEAE-cellulose (Whatman DE- 
52) and was digested with trypsin (196, w/w). The resulting peptides 
were isolated by high-voltage paper electrophoresis at pH 6.5 followed 
by descending chromatography [19]. After visualization with fluores- 
camine, peptides were identified by amino acid analysis. The T16 
peptide was further analyzed by thermolytic digestion (28, w/w) at 
50°C in 0.1 M NH4HC03, pH 8.9, using a peptide concentration of 
0.5 nmol/,ul. The resulting thermolytic peptides were separated again 
by high-voltage lectrophoresis at pH 6.5. 
In vitro deamidation of a-crystallin and purified &B-subunits from 
6-month-old calves was performed under vacuum in 0.1 M sodium 
phosphate buffer, pH 7.4. at 70°C using a protein concentration of 
10 nmoU150 ~1 [20]. Incubations were terminated at different time 
intervals by short dialysis and subsequent lyophilization. D/L-Aspartic 
acid ratios (or % ~-Asp) were determined after isolation of Asp- 
containing peptides as described [21,22]. 
Alkaline urea gel electrophoresis was carried out at pH 8.5 [19]. 
Two-dimensional gel electrophoresis was performed according to 
O’Farrell 1231. 
3. RESULTS 
Analysis by two-dimensional gel electrophoresis of 
a-crystallin isolated from the water-soluble fraction of 
Published by Elsevier Science Publishers B. V. 69 
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Fig. 1. Coomassie brilliant blue-stained two-dimensional gel pattern 
of acrystallin, isolated from the water-soluble fraction from 75 to 
85-year-old human lenses. The superscripts d.p and rr indicate the 
presumed eamidated, mono- and di-phosphorylated a-crystallin sub- 
units. 
75- to 85-year-old human lenses reveals a characteristic 
pattern, composed of aA- and aB-crystallin and several 
posttranslational modification products (Fig. 1). It is 
known from earlier studies that bovine aA- and aB- 
crystallin both undergo phosphorylation [24-261 and 
that aA-crystallin in addition undergoes site-specific 
deamidation of Asn-101, which is accompanied by 
isomerization, racemization and peptide bond cleavage 
[18]. Also in human aA-crystallin conspicuous deami- 
dation of Asn-101 has been observed [27]. No evidence 
has been provided yet for the occurrence of deamidation 
in aB-crystallin, although Kramps [27] isolated from 
human, but not from bovine a-crystallin, an aB-subunit 
that he suspected to be deamidated. Indeed, the two- 
dimensional gel pattern of human a-crystallin shows a 
spot with one more negative charge than aB-crystallin, 
responding positively to an antiserum specific for aB- 
crystallin (data not shown), indicative for a deamidated 
aB-crystallin product. There are only 4 amino acid dif- 
ferences between bovine and human aB-crystallin 
[28,29], not involving the sequences urrounding the 
only two asparaginyl residues. For this reason and be- 
cause bovine lenses were more easy to obtain, the in 
vitro and in vivo deamidation of ccB-crystallin was stud- 
ied using bovine a-crystallin. 
Bovine aB-crystallin undergoes a single charge differ- 
ence upon incubation in 100 mM phosphate buffer pH 
7.4 at 7O”C, conditions that favor succinimide forma- 
tion [20,30,31] (Fig. 2, lanes 2,3). This presumed eami- 
dation process of aB-crystallin proceeds very quickly, 
the tin value is 8 h. To find out if this charge difference 
is indeed due to the deamidation of an asparaginyl res- 
idue, tryptic peptide mapping of the native and modi- 
fied aB-crystallin was performed. The tryptic peptide 
maps of the two chains were identical apart from a 
change in mobility of a single peptide (Fig. 3). Upon 
analysis of the amino acid composition, this peptide was 
identified as T16, comprising residues 124-149 of the 
aB chain [28]. This peptide contains an Asn residue at 
position 146 that is flanked by a glycyl residue. In addi- 
tion to Asn-146 there are in this peptide three Asp resi- 
dues (positions 127, 129 and 140) of which Asp-140 is 
also followed by Gly. It is known that Asn-Gly se- 
quences are particularly prone to deamidation via suc- 
cinimide formation, which leads to isomerization and 
racemization as well [20]. Similarly, Asp-Gly sequences 
can easily form succinimide rings, again leading to en- 
hanced isomerization and racemization. To check 
whether racemization occurs concomitantly during 
deamidation of aB-crystallin, the percentage of ~-Asp 
in the tryptic peptide T16 and its thermolytic fragments 
were determined. Table I shows that the level of racemi- 
zation of T16 increases from 2.2% to 17.3% during 96 
h of incubation. This increase is largely accounted for 
by the strong racemization of deamidated Asn-146 
(T16Th4d) and Asp-140 (T16Th3). The level of ~-Asp 
of other aspartyl residues hardly increases upon in vitro 
incubation. 
To assess whether deamidation of aB-crystallin also 
occurs in vivo, a-crystallin was isolated from j-year-old 
bovine lens nuclei. This fraction contains a band that 
corresponds in electrophoretic mobility with the in vitro 
deamidated &B-product (Fig. 2, lane 4). The amount of 
this product relative to the unmodified aB-chain in 5- 
year-old a-crystallin is estimated at about 20%, whereas 
in young a-crystallin this product is absent (Fig. 2, lane 
1). These data clearly point out that the deamidation of 
aB-crystallin is an age-dependent process. The sup- 
posed deamidated &B-product was purified by means of 
CfB- 
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Fig, 2. Alkaline urea gel electrophoresis pattern showing deamidation 
of al-crystallin. (1) aCrystallin isolated from the water-soluble frac- 
tion of calf lens cortex (35 pug), (2) ccl-crystallin isolated from calf lens 
cortex (5 pug), (3) al-crystallin, in vitro deamidated for 7 h at 70°C 
under vacuum (12.5 pg), (4) a-crystallin isolated from the water- 
soluble fraction of 5-year-old bovine lens nuclei (75 pg), (5) aBd- 
crystallin, isolated from 5-year-old bovine lens nuclei (20 pug). The in 
vitro and in vivo aBd-product is located between aB-crystallin and the 
monophosphorylated aBP-crystallin, demonstrating a single addi- 
tional negative charge in aBd- relative to cclcrystallin. 
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Fig. 3. Peptide map of tryptic digest of bovine aB-crystallin. The arrow indicates the displacement of T16 (dashed) in the deamidated uB-chain. 
This displacement was found both upon in vitro deamidation (incubation time 24 h) and in the in vivo deamidated uB-crystallin isolated from 
5-year-old bovine lens nuclei. 
anion-exchange chromatography (Fig. 2, lane 5). Tryp- 
tic peptide mapping revealed again the displacement of 
T16, demonstrating that Asn-146 of bovine aB-crys- 
tallin deamidates in vivo as well. The identification of 
Asn-146 as site of deamidation is supported by the find- 
ing that chicken aB-crystallin, which lacks the corre- 
sponding Asn residue, is not deamidated at all in lo- 
year-old lenses (see Fig. 3 in [17]). 
4. DISCUSSION 
The number of well-characterized in vivo deamida- 
tion sites in cellular proteins is still quite limited [32,33]. 
In only a few proteins, particularly the long-living lens 
Table I 
Racemization of aspartyl residues of aB-crystallin after in vitro incu- 
bation in 0.1 M sodium phosphate buffer, pH 7.4 at 7O’C. Values are 
the mean of two independent incubations; percentages of ~-Asp were 
measured in triplicate. 
Peptides as indicated % ~-Asp % D-ASP 
t=O t=96h 
T16 : Ala-Asp’27-Val-Asp’Z9-Pro 
Ser-Asp’N-Gly 2.2% _ 
Val-Asn’46-Gly 
T16* : Asn’46 -+ Asp’& _ 17.3% 
T16Thl : Ala-Asp’27-Val-Asp’29-Pro 1.5% 5.2% 
T16Th3 : Ser-Asp’@-Gly 2.3% 24.2% 
T16Th4 : Val-Asn’46-Gly 2.3% - 
T16Th4* : Asn’& + Asp’& _ 28.7% 
T4 : Ile-Asp6*-Thr 2.9% 6.7% 
T6 : Lys-Asp73-Arg 2.0% 4.1% 
T12 : Gln-AsplOg-Glu 1.8% 2.7% 
* Peptides T4, T6 and T12 are included for comparison. 
crystallins, deamidation has been correlated with aging 
[34]. Besides the site-specific, age-dependent deamida- 
tion in chicken, bovine and human aA-crystallin 
[17,18,27], we now provide evidence that also bovine 
aB-crystallin undergoes site-specific deamidation at 
Asn-146, both during in vitro incubation and upon in 
vivo aging of this protein in the lens. The deamidated 
aB-crystallin reaches a level of at least 20% in 5-year-old 
bovine lens nuclei, whereas it is not detectable in 6- 
month-old calf lens cortex. High levels of deamidated 
aB-crystallin can also be observed in 75- to 85-year-old 
human lenses (Fig. l), while this modification product 
is not detectable in fetal human lenses (see Fig. 1B in 
[351)* 
Because aB-crystallin rapidly deamidates in vitro 
under conditions that favor succinimide formation and 
because of the pronounced racemization that was found 
to accompany the site-specific deamidation, we assume 
that the deamidation of aB-crystallin under physiologi- 
cal conditions in the lens also proceeds through an 
imide intermediate. It is known from previous studies 
that the rate of succinimide-mediated reactions is 
strongly influenced by the surrounding residues 
[20,36,37]. Amino acids at the amino side of Asn or Asp 
have little or no effect, whereas amino acids at the car- 
boxylic side of Asn or Asp affect the imide ring forma- 
tion significantly. In general, the rate of succinimide- 
linked reactions is decreased as the size and steric bulk 
of the carboxylic flanking residue increases. Hence, 
Asn-Gly sequences easily undergo deamidation. Here 
we demonstrate that deamidation of bovine aB-crys- 
tallin actually occurs at Asn-146Gly-147. However, 
the rate of in vivo deamidation at Asn-146 is low, indi- 
cating conformational constraints on the deamidation 
process [32]. The only other asparagine residue present 
71 
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in bovine (and human) aB-crystallin (Asn-78) is flanked 
by a bulky leucine residue and does not deamidate. 
Imide ring formation at aspartic acid residues, which 
recently has been demonstrated to occur in vivo [38], 
leads to their isomerization and racemization. In previ- 
ous studies, it has been inferred that this process takes 
place in bovine aA-crystallin of which a single aspartyl 
residue exhibits pronounced age-dependent racemiza- 
tion [22,39]. A similar modification has now been found 
in olB-crystallin. Among the 3 aspartyl residues in T16, 
only Asp- 140 becomes trongly racemized upon incuba- 
tion of aB-crystallin under conditions that favor succin- 
imide formation. Like Asn-146, this Asp-140 is flanked 
by a glycine residue at the carboxylic side. 
It is not clear whether deamidation of aB-crystallin 
has any influence on its functioning as a lens structural 
protein. Outside the lens, however, the role of aB-crys- 
tallin as a stress protein will probably not be affected by 
this modification because of the low deamidation rate 
at 37°C. 
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